De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,715 followers.

RT @FrontOncology: New research: De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes und…

02 Nov 2023

Reply Repost Favourite

New research: De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy: Background In the era of anti-HER2 targeted therapy, the potential clinical feasibility… https://t.

02 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.